memantine hydrochloride 2 MG/ML Oral Solution

What the CMS Formulary Data Shows for memantine hydrochloride 2 MG/ML Oral Solution

Per the CMS 2026 Part D formulary file, memantine hydrochloride 2 MG/ML Oral Solution (RxNorm concept RXCUI 996740, generic name memantine hydrochloride) appears on 292 distinct formulary files spanning 4,820 Medicare Part D plan offerings - 95.1% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.8.

Real-world access to memantine hydrochloride 2 MG/ML Oral Solution depends on utilization management as much as tier placement: 56.5% of covering formularies require prior authorization. 0% require step therapy. 42.1% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 892,907 Part D beneficiaries filled memantine hydrochloride 2 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $207,922,964 and an average per-beneficiary annual cost of $232.86. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry memantine hydrochloride 2 MG/ML Oral Solution today.